Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891937954> ?p ?o ?g. }
- W2891937954 endingPage "73" @default.
- W2891937954 startingPage "55" @default.
- W2891937954 abstract "The purpose of this study was to review the published evidence on the clinical use of nonsteroidal anti-inflammatory drugs (NSAIDs) and to assess the cardiovascular risk (CVR) of cyclooxygenase-2 inhibitors (coxibs), excluding aspirin, by means of a meta-analytic procedure. A search was conducted on MEDLINE and EMBASE databases between October 1999 and June 2018. Cohort and case-control studies showing CVR as relative risk (RR), odds ratio, hazard ratio, or incidence rate ratio associated with NSAIDs versus no treatment were selected. We estimated the pooled RR and the 95% confidence interval (CI) for all NSAIDs as a whole and individually. Eighty-seven studies met the inclusion criteria. Overall, NSAIDs were found to be associated with a statistically significantly increased CVR (RR, 1.24 [95%CI, 1.19-1.28]). The risk was slightly higher for coxibs (RR, 1.22 [95%CI, 1.17-1.28]) as compared with nonselective NSAIDs (RR, 1.18 [95%CI, 1.12-1.24]). Data analysis by drug disclosed that rofecoxib (RR, 1.39 [95%CI, 1.31-1.47]), followed by diclofenac (RR, 1.34 [95%CI, 1.26-1.42]) and etoricoxib (RR, 1.27 [95%CI, 1.12-1.43]) were the NSAIDs associated with the highest CVR. Analysis by type of event showed that the highest risk corresponded to vascular events for both coxibs (RR, 2.18 [95%CI, 1.72-2.78]) and nonselective NSAIDs (RR, 2.46 [95%CI, 2.00-3.02]). The meta-analysis results suggest that the use of the marketed coxibs celecoxib and etoricoxib would be related to a statistically significant CVR increase. Etoricoxib CVR could be higher than that for celecoxib. This increment would be similar to classical NSAID CVR." @default.
- W2891937954 created "2018-09-27" @default.
- W2891937954 creator A5013063589 @default.
- W2891937954 creator A5018339918 @default.
- W2891937954 creator A5018626783 @default.
- W2891937954 creator A5061475892 @default.
- W2891937954 date "2018-09-11" @default.
- W2891937954 modified "2023-10-12" @default.
- W2891937954 title "Cardiovascular Risk of Nonsteroidal Anti‐inflammatory Drugs and Classical and Selective Cyclooxygenase‐2 Inhibitors: A Meta‐analysis of Observational Studies" @default.
- W2891937954 cites W1174596620 @default.
- W2891937954 cites W1539877514 @default.
- W2891937954 cites W1567315743 @default.
- W2891937954 cites W1594852893 @default.
- W2891937954 cites W1599185368 @default.
- W2891937954 cites W1608766509 @default.
- W2891937954 cites W1753389293 @default.
- W2891937954 cites W1918652666 @default.
- W2891937954 cites W1928620804 @default.
- W2891937954 cites W1970351453 @default.
- W2891937954 cites W1971207139 @default.
- W2891937954 cites W1979392296 @default.
- W2891937954 cites W1983393465 @default.
- W2891937954 cites W1985210212 @default.
- W2891937954 cites W1986868049 @default.
- W2891937954 cites W1988980877 @default.
- W2891937954 cites W1989480380 @default.
- W2891937954 cites W1993247276 @default.
- W2891937954 cites W1993961357 @default.
- W2891937954 cites W2002178040 @default.
- W2891937954 cites W2007057990 @default.
- W2891937954 cites W2008333987 @default.
- W2891937954 cites W2010501723 @default.
- W2891937954 cites W2010818945 @default.
- W2891937954 cites W2010899039 @default.
- W2891937954 cites W2011994711 @default.
- W2891937954 cites W2012920835 @default.
- W2891937954 cites W2016954448 @default.
- W2891937954 cites W2017251217 @default.
- W2891937954 cites W2018501386 @default.
- W2891937954 cites W2020036206 @default.
- W2891937954 cites W2020097916 @default.
- W2891937954 cites W2021580807 @default.
- W2891937954 cites W2023997066 @default.
- W2891937954 cites W2034412869 @default.
- W2891937954 cites W2037532153 @default.
- W2891937954 cites W2038932922 @default.
- W2891937954 cites W2046536696 @default.
- W2891937954 cites W2050267707 @default.
- W2891937954 cites W2052530234 @default.
- W2891937954 cites W2052731213 @default.
- W2891937954 cites W2063252400 @default.
- W2891937954 cites W2065019033 @default.
- W2891937954 cites W2065748354 @default.
- W2891937954 cites W2067621583 @default.
- W2891937954 cites W2070469088 @default.
- W2891937954 cites W2075300189 @default.
- W2891937954 cites W2076263459 @default.
- W2891937954 cites W2079003073 @default.
- W2891937954 cites W2082064600 @default.
- W2891937954 cites W2084235819 @default.
- W2891937954 cites W2090531910 @default.
- W2891937954 cites W2098648996 @default.
- W2891937954 cites W2098914518 @default.
- W2891937954 cites W2100024933 @default.
- W2891937954 cites W2100099388 @default.
- W2891937954 cites W2100568225 @default.
- W2891937954 cites W2100631748 @default.
- W2891937954 cites W2106974656 @default.
- W2891937954 cites W2107328434 @default.
- W2891937954 cites W2109621899 @default.
- W2891937954 cites W2114405303 @default.
- W2891937954 cites W2122463896 @default.
- W2891937954 cites W2123431896 @default.
- W2891937954 cites W2126930838 @default.
- W2891937954 cites W2129584145 @default.
- W2891937954 cites W2130000778 @default.
- W2891937954 cites W2130517249 @default.
- W2891937954 cites W2132795413 @default.
- W2891937954 cites W2134239441 @default.
- W2891937954 cites W2134404484 @default.
- W2891937954 cites W2134617241 @default.
- W2891937954 cites W2135900226 @default.
- W2891937954 cites W2136555831 @default.
- W2891937954 cites W2139373014 @default.
- W2891937954 cites W2148193549 @default.
- W2891937954 cites W2148359829 @default.
- W2891937954 cites W2156958131 @default.
- W2891937954 cites W2157823046 @default.
- W2891937954 cites W2158131645 @default.
- W2891937954 cites W2160921747 @default.
- W2891937954 cites W2165039186 @default.
- W2891937954 cites W2166375212 @default.
- W2891937954 cites W2169603070 @default.
- W2891937954 cites W2170622194 @default.
- W2891937954 cites W2172253009 @default.
- W2891937954 cites W2204564504 @default.
- W2891937954 cites W2220550414 @default.
- W2891937954 cites W2330496155 @default.